Helicobacter Pylori Non-Invasive Testing Market

Helicobacter pylori is a type of bacteria that is known to be a major cause of peptic ulcers, which are sores on the lining of the esophagus, stomach or small intestine. H. pylori testing detects an infection of the digestive tract caused by the bacteria to help diagnose the cause of symptoms and/or ulcers.

H. pylori infections of the digestive tract are very common, with as many as half of the world?s population infected. However, most people with H. pylori never have any symptoms. Still, H. pylori infection increases the risk of developing ulcers (peptic ulcer disease), persistent stomach inflammation (gastritis), and gastric (stomach) cancer. The bacteria decrease the stomach?s ability to produce mucus, making the stomach prone to damage from digestive acid and peptic ulcers.

Helicobacter Pylori Non-Invasive Testing Market contains market size and forecasts of Helicobacter Pylori Non-Invasive Testing in Global, including the following market information:

Global Helicobacter Pylori Non-Invasive Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Helicobacter Pylori Non-Invasive Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Serologic Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Helicobacter Pylori Non-Invasive Testing include Abbott, Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories and EKF Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Helicobacter Pylori Non-Invasive Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Helicobacter Pylori Non-Invasive Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Helicobacter Pylori Non-Invasive Testing Market Segment Percentages, by Type, 2021 (%)

Serologic Test

Urea Breath Test (UBT)

Stool Antigen Test (SAT)

Global Helicobacter Pylori Non-Invasive Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Helicobacter Pylori Non-Invasive Testing Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Diagnostic Laboratories

Others

Global Helicobacter Pylori Non-Invasive Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Helicobacter Pylori Non-Invasive Testing Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Helicobacter Pylori Non-Invasive Testing revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Helicobacter Pylori Non-Invasive Testing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Sekisui Diagnostics

F. Hoffmann-La Roche

Medline Industries

Meridian Bioscience

Bio-Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health, Inc

Cardinal Health

Beckman Coulter Inc

Agilent Technologies

Coris BioConcept